PKS21004

CAS: 2095521-90-5

Ref. 3D-VID52190

Produktinformation

• Name: PKS21004

Beschreibung

PKS21004 is a noncompetitive inhibitor of the immunoproteasome that binds to the catalytic subunit. It has been shown to be effective in the treatment of infectious diseases, autoimmune diseases, and cancer. The drug targets the proteasome by binding to the catalytic subunit, which inhibits its function and prevents protein degradation. PKS21004 also induces apoptotic cell death in cells with high levels of immunoproteasomes. This drug has been shown to be effective in treating inflammatory diseases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 542.67 g/mol
• Formel: C₃₂H₃₈N₄O₄
• Reinheit: Min. 95%